» Articles » PMID: 11352872

NAT2 Acetylator Genotypes Confer No Effect on the Risk of Developing Adult Acute Leukemia: a Case-control Study

Overview
Date 2001 May 16
PMID 11352872
Citations 3
Authors
Affiliations
Soon will be listed here.
Citing Articles

Association between NAT2 polymorphisms and acute leukemia risk: A meta-analysis.

Zhu X, Liu Y, Chen G, Guo Q, Zhang Z, Zhao L Medicine (Baltimore). 2019; 98(12):e14942.

PMID: 30896661 PMC: 6709067. DOI: 10.1097/MD.0000000000014942.


N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Kamel A, Ebid G, Moussa H Tumour Biol. 2015; 36(8):6341-8.

PMID: 25804798 DOI: 10.1007/s13277-015-3320-7.


CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.

Silveira V, Canalle R, Scrideli C, Queiroz R, Lopes L, Tone L Mol Cell Biochem. 2012; 364(1-2):217-23.

PMID: 22215203 DOI: 10.1007/s11010-011-1220-8.